Medicure was founded in 1997 and became a public company in November 1999. The company trades under the symbol MPH on the TSX Venture Exchange. As a U.S focused Specialty Pharma company with established sales of Aggrastat, Medicure carefully monitors opportunities within its own pipeline of products and possible acquisitions of related pharma companies in order to realize long term value.
Quarterly and Annual financial reports will be posted below after release.
Effective Dec 18, 2014 the Fiscal Year End was changed to December 31 from May 31.
Financial Reports for 2016 listed below:
Financial Reports for 2015 listed below:
Financial Reports for 2014 listed below:
Financial Reports for 2013 listed below:
Financial Reports for 2012 listed below: